Opaleye Management Inc. Quant / Systematic

Location: BOSTON, MA

CIK: 0001595855 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $759M (100.0% shares, 0.0% debt)

Holdings (54)

New Positions (10)

Increased Positions (14)

SLGL SOL-GEL TECHNOLOGIES LTD 5.2%
Value $39.61M (+107.2%) Shares 500,000 (+10.2%) Est. Cost Unrealized
URGN UROGEN PHARMA LTD 3.4%
Value $25.71M (+309.0%) Shares 1,430,000 (+432.7%) Est. Cost Unrealized
MGTX MEIRAGTX HLDGS PLC 2.4%
Value $18.39M (+491.8%) Shares 2,123,259 (+443.2%) Est. Cost Unrealized
CATX PERSPECTIVE THERAPEUTICS INC 2.6%
Value $19.49M (+290.7%) Shares 4,675,000 (+294.7%) Est. Cost Unrealized
IRON DISC MEDICINE INC 3.5%
Value $26.92M (+69.5%) Shares 421,000 (+110.5%) Est. Cost Unrealized
CBIO CRESCENT BIOPHARMA INC. 3.2%
Value $24.11M (+72.5%) Shares 1,312,615 (+11.4%) Est. Cost Unrealized
QTTB Q32 BIO INC 1.1%
Value $8.065M (+1038.5%) Shares 1,256,228 (+488.8%) Est. Cost Unrealized
ALMS ALUMIS INC 1.6%
Value $12.12M (+132.0%) Shares 550,000 (+2.8%) Est. Cost Unrealized
LQDA LIQUIDIA CORPORATION 11.7%
Value $88.82M (+4.5%) Shares 2,545,000 (+4.5%) Est. Cost Unrealized
CABA CABALETTA BIO INC 0.5%
Value $3.712M (+88.3%) Shares 1,380,000 (+53.3%) Est. Cost Unrealized
XOMA XOMA ROYALTY CORPORATION 1.2%
Value $9.411M (+21.0%) Shares 300,000 (+2.5%) Est. Cost Unrealized
AVIR ATEA PHARMACEUTICALS INC 0.2%
Value $1.736M (+170.4%) Shares 322,600 (+79.4%) Est. Cost Unrealized
ACOG ALPHA COGNITION INC 1.9%
Value $14.07M (+4.5%) Shares 2,561,950 (+23.7%) Est. Cost Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.2%
Value $1.579M (+33.5%) Shares 125,000 (+66.7%) Est. Cost Unrealized

Exited Positions (10)

Decreased Positions (11)

Unchanged Positions (19)

ETON ETON PHARMACEUTICALS INC 9.3%
Value $70.58M Shares 2,860,000 Est. Cost Unrealized
SNWV SANUWAVE HEALTH INC 2.2%
Value $16.97M Shares 981,267 Est. Cost Unrealized
RZLT REZOLUTE INC 2.5%
Value $19.21M Shares 6,300,000 Est. Cost Unrealized
APGE APOGEE THERAPEUTICS INC 4.3%
Value $32.83M Shares 390,000 Est. Cost Unrealized
EWTX EDGEWISE THERAPEUTICS INC 2.1%
Value $15.75M Shares 500,000 Est. Cost Unrealized
STRO SUTRO BIOPHARMA INC 0.6%
Value $4.75M Shares 190,671 Est. Cost Unrealized
RLMD RELMADA THERAPEUTICS INC 0.9%
Value $6.508M Shares 935,000 Est. Cost Unrealized
TGTX TG THERAPEUTICS INC 2.3%
Value $17.77M Shares 535,000 Est. Cost Unrealized
RVMD REVOLUTION MEDICINES INC 1.3%
Value $9.725M Shares 100,000 Est. Cost Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.4%
Value $3.306M Shares 1,412,656 Est. Cost Unrealized
RIGL RIGEL PHARMACEUTICALS INC 0.2%
Value $1.893M Shares 70,000 Est. Cost Unrealized
STOK STOKE THERAPEUTICS INC 3.0%
Value $22.79M Shares 700,000 Est. Cost Unrealized
JBIO JADE BIOSCIENCES INC 0.8%
Value $6.008M Shares 427,608 Est. Cost Unrealized
MBX MBX BIOSCIENCES INC 1.0%
Value $7.761M Shares 260,000 Est. Cost Unrealized
TRVI TREVI THERAPEUTICS INC 0.5%
Value $4.117M Shares 345,100 Est. Cost Unrealized
RCKT ROCKET PHARMACEUTICALS INC 0.5%
Value $3.419M Shares 955,000 Est. Cost Unrealized
CDXS CODEXIS INC 1.5%
Value $11.06M Shares 6,785,000 Est. Cost Unrealized
ADGM ADAGIO MED HLDGS INC 0.0%
Value $21,211 Shares 18,444 Est. Cost Unrealized
IRD OPUS GENETICS INC 0.3%
Value $2.251M Shares 1,120,000 Est. Cost Unrealized